1. Home
  2. ENOV vs CERT Comparison

ENOV vs CERT Comparison

Compare ENOV & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • CERT
  • Stock Information
  • Founded
  • ENOV 1995
  • CERT 2008
  • Country
  • ENOV United States
  • CERT United States
  • Employees
  • ENOV N/A
  • CERT N/A
  • Industry
  • ENOV Fluid Controls
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • ENOV Industrials
  • CERT Technology
  • Exchange
  • ENOV Nasdaq
  • CERT Nasdaq
  • Market Cap
  • ENOV 2.1B
  • CERT 2.3B
  • IPO Year
  • ENOV 2008
  • CERT 2020
  • Fundamental
  • Price
  • ENOV $33.10
  • CERT $11.87
  • Analyst Decision
  • ENOV Buy
  • CERT Buy
  • Analyst Count
  • ENOV 4
  • CERT 6
  • Target Price
  • ENOV $58.50
  • CERT $15.60
  • AVG Volume (30 Days)
  • ENOV 986.0K
  • CERT 2.9M
  • Earning Date
  • ENOV 05-08-2025
  • CERT 05-05-2025
  • Dividend Yield
  • ENOV N/A
  • CERT N/A
  • EPS Growth
  • ENOV N/A
  • CERT N/A
  • EPS
  • ENOV N/A
  • CERT N/A
  • Revenue
  • ENOV $2,150,191,000.00
  • CERT $394,498,000.00
  • Revenue This Year
  • ENOV $7.13
  • CERT $11.41
  • Revenue Next Year
  • ENOV $6.33
  • CERT $8.78
  • P/E Ratio
  • ENOV N/A
  • CERT N/A
  • Revenue Growth
  • ENOV 18.32
  • CERT 9.37
  • 52 Week Low
  • ENOV $29.32
  • CERT $8.64
  • 52 Week High
  • ENOV $53.84
  • CERT $17.94
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 41.77
  • CERT 44.02
  • Support Level
  • ENOV $33.48
  • CERT $11.22
  • Resistance Level
  • ENOV $35.62
  • CERT $13.18
  • Average True Range (ATR)
  • ENOV 1.32
  • CERT 0.72
  • MACD
  • ENOV 0.20
  • CERT -0.34
  • Stochastic Oscillator
  • ENOV 49.20
  • CERT 15.73

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: